In this episode of the Alternate View, Matt Hellauer of PTX Capital takes us inside the heart of healthcare venture capital, breaking down how deals are sourced, how founders are evaluated, where valuations are heading, and why healthcare innovation is exploding.
Whether you’re an RIA, sophisticated investor, or just alternatives-curious, this conversation pulls back the curtain on how real venture investors think, from due diligence to portfolio construction to identifying founders who become outliers.
We cover: • How PTX Capital identifies high-impact healthcare companies • Why founder psychology matters more than pitch decks • What LPs misunderstand about venture investing • The shift from growth-at-all-costs to capital discipline • How Baltimore’s emerging startup ecosystem is changing the game • Practical insights for advisors and investors allocating to alternatives
00:00 – Intro 00:45 – Matt Hellauer on PTX Capital’s mission 03:10 – How founders are evaluated 06:25 – The state of venture capital 10:40 – Where healthcare innovation is heading 15:55 – Risk, portfolio construction & LP expectations 21:30 – What advisors should know about private markets 27:00 – Baltimore’s rising startup ecosystem 33:45 – Final takeaways
If you’re looking to deepen your understanding of venture capital, private markets, and the future of healthcare innovation, you’re in the right place.
🔗 Links All Episodes at: https://AlternateView.FM PTX Capital: https://www.ptxcap.com
Podden och tillhörande omslagsbild på den här sidan tillhör
Matt Andrulot. Innehållet i podden är skapat av Matt Andrulot och inte av,
eller tillsammans med, Poddtoppen.
